Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 86,300 | 91,800 | 82,500 | 185,400 | 117,200 |
| Depreciation Amortization | 197,100 | 199,300 | 174,600 | 163,800 | 137,200 |
| Income taxes - deferred | -19,800 | -15,500 | 2,200 | 26,400 | 73,500 |
| Accounts receivable | -3,500 | -3,200 | -14,300 | -13,600 | -10,900 |
| Accounts payable and accrued liabilities | -13,200 | -1,300 | -8,600 | 29,800 | 28,200 |
| Other Working Capital | -40,600 | 75,900 | 50,100 | 102,000 | 24,000 |
| Other Operating Activity | 98,100 | 39,400 | 100,900 | -17,700 | 4,000 |
| Operating Cash Flow | $304,400 | $386,400 | $387,400 | $476,100 | $373,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -117,600 | -86,800 | -87,000 | -115,400 | -88,600 |
| Net Acquisitions | -34,100 | -156,800 | -223,600 | -97,600 | N/A |
| Purchase Of Investment | N/A | N/A | -9,900 | N/A | -34,000 |
| Sale Of Investment | N/A | N/A | 14,300 | 9,200 | 1,900 |
| Other Investing Activity | 0 | 600 | 0 | 21,900 | 5,700 |
| Investing Cash Flow | $-151,700 | $-243,000 | $-306,200 | $-181,900 | $-115,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 140,400 | N/A | 1,650,000 | 315,000 | -240,000 |
| Debt Issued | 17,900 | N/A | N/A | 221,200 | 155,300 |
| Debt Repayment | -172,700 | -22,800 | -927,700 | -31,100 | -244,400 |
| Common Stock Issued | 16,100 | 18,400 | 19,800 | 47,900 | 321,700 |
| Common Stock Repurchased | N/A | -10,000 | N/A | N/A | N/A |
| Dividend Paid | -179,600 | -175,900 | -842,200 | -799,300 | -19,800 |
| Other Financing Activity | -8,900 | -700 | -26,000 | -35,100 | -23,000 |
| Financing Cash Flow | $-186,800 | $-191,000 | $-126,100 | $-281,400 | $-50,200 |
| Beginning Cash Position | 196,300 | 243,900 | 288,800 | 276,000 | 68,000 |
| End Cash Position | 162,200 | 196,300 | 243,900 | 288,800 | 276,000 |
| Net Cash Flow | $-34,100 | $-47,600 | $-44,900 | $12,800 | $208,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 304,400 | 386,400 | 387,400 | 476,100 | 373,200 |
| Capital Expenditure | -124,700 | -144,500 | -124,300 | -137,500 | -108,200 |
| Free Cash Flow | 179,700 | 241,900 | 263,100 | 338,600 | 265,000 |